U.S. market Closed. Opens in 1 day 4 hours 30 minutes

TCRT | Alaunos Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-31
Revenue5.00K2.92M398.00KN/AN/A146.00K6.39M6.86M4.33M1.37M800.00K800.00K667.00KN/AN/AN/AN/AN/AN/AN/AN/A2.57K1.73K
Cost of Revenue4.80M2.76M740.00K1.13M629.00KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Gross Profit-4.80M163.00K-342.00K-1.13M-629.00K146.00K6.39M6.86M4.33M1.37M800.00K800.00K667.00KN/AN/AN/AN/AN/AN/AN/AN/A2.57K1.73K
Operating Expenses29.47M38.16M77.21M80.36M57.86M54.05M59.88M172.17M124.43M44.87M58.51M102.97M72.07M24.55M12.12M25.62M28.57M19.11M9.79M39.17K35.84K42.51K74.26K
Selling, General & Admin12.22M13.14M27.56M27.66M19.53M19.92M14.80M14.38M17.65M12.17M15.66M19.52M14.98M11.64M7.57M8.37M9.58M8.72M4.19M39.17K35.36KN/A120.00
Research & Development16.28M25.02M49.64M52.70M38.33M34.13M45.08M157.79M106.78M32.71M42.85M83.45M57.08M12.91M4.56M17.25M18.99M10.39M5.59MN/AN/AN/AN/A
Other Operating Expenses971.00K529.00K-1.20M385.00K813.00K631.00K465.00K134.00K12.00K-5.00K-579.00K-13.00KN/AN/AN/AN/AN/A10.39MN/AN/A486.0042.51K74.14K
Operating Income-34.27M-35.10M-77.55M-80.36M2.26M-53.91M-53.49M-165.31M-120.10M-43.50M-57.71M-102.17M-71.40M-24.55M-12.12M-25.62M-28.57M-19.11M-9.79M-39.17K-35.84K-39.94K-72.53K
Other Expenses / Income-873.00K-2.62M-1.20M385.00K-59.94M789.00K-830.00K10.00K12.00K11.72M606.00K6.04M7.62M-8.12M4.47M388.00K1.96M1.25M270.48KN/AN/AN/AN/A
Before Tax Income-35.14M-37.73M-78.75M-79.98M-117.80M-53.12M-54.32M-165.30M-120.09M-31.78M-57.11M-96.13M-63.78M-32.67M-7.65M-25.23MN/A-17.86MN/A-39.17K-35.84K-39.94K-72.53K
Income Tax ExpensesN/A-133.00K-1.86M-1.13M60.12M-947.00K2.12M114.00K-12.00K-23.44M-1.79M-12.09M-15.24M16.25M-8.95M-388.00K-1.96M-1.25M-270.48KN/AN/AN/AN/A
Net Income-35.14M-37.60M-76.89M-78.85M-177.92M-53.12M-54.32M-165.30M-120.09M-31.78M-57.11M-96.13M-63.78M-32.67M-7.65M-25.23M-26.61M-17.86M-9.52M-39.17K-35.84K-39.94K-72.53K
Interest Expenses1.92M3.15M1.18MN/AN/AN/A830.00KN/AN/AN/AN/AN/AN/A8.12MN/AN/AN/AN/AN/AN/AN/AN/AN/A
Basic Shares Outstanding1.60M1.45M1.43M1.40M1.12M956.72K912.92K869.28K836.11K674.20K572.95K523.64K440.02K306.69K154.05K141.55K125.55K83.81K36.21K993.001.96K1.49K1.49K
Diluted Shares Outstanding1.60M1.45M1.43M1.40M1.12M958.07K912.92K869.28K836.11K674.20K572.95K523.64K440.02K306.69K154.05K141.55K125.55K83.81K36.21K993.001.96K1.49K1.49K
EBITDA-30.90M-31.82M-74.97M-78.85M-117.17M-53.33M-53.12M-165.01M-119.73M-43.50M-56.98M-102.17M-71.40M-32.48M-7.32M-24.84M-26.17M-17.68M-9.42M-5.65M-35.36K-39.14K-71.78K
EBITDA Margin-618,080.00%-1,088.88%-18,837.19%0.00%0.00%-36,528.08%-831.49%-2,405.00%-2,763.87%-3,168.17%-7,121.88%-12,771.13%-10,704.65%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-1,523.04%-4,159.04%
EBIT-33.22M-34.58M-77.57M-79.98M-117.80M-54.06M-51.37M-165.18M-120.10M-55.22M-58.90M-108.22M-79.02M-8.30M-16.60M-25.62M-28.57M-19.11M-9.79M-39.17K-35.84K-39.94K-72.53K
EBIT Margin-664,380.00%-1,183.30%-19,489.70%0.00%0.00%-37,030.14%-804.01%-2,407.56%-2,772.39%-4,022.00%-7,362.25%-13,527.38%-11,847.38%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-1,554.12%-4,202.49%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙